Abstract:Background: The search for biomarkers of appetite is very active. Objectives: The aims were to compare dynamics of hunger and fullness ratings on a visual analog scale (VAS) with dynamics of glucagon-like peptide 1, peptide tyrosine-tyrosine, ghrelin, glucose, and insulin concentrations throughout different meal patterns-and thus different timings of nutrient delivery to the gut-by using a statistical approach that focuses on within-subject relations of these observations and to investigate whether appetite ra… Show more
“…It is clear that all peptides associate strongly with feelings of being satiated. This agrees with findings by Lemmens et al [33], despite the differences in VAS questions asked between both studies. Unfortunately, in the present study ghrelin was not evaluated.…”
Section: The Satiating Effect Of Nutralys® Pea Protein Leads To Reducsupporting
“…It is clear that all peptides associate strongly with feelings of being satiated. This agrees with findings by Lemmens et al [33], despite the differences in VAS questions asked between both studies. Unfortunately, in the present study ghrelin was not evaluated.…”
Section: The Satiating Effect Of Nutralys® Pea Protein Leads To Reducsupporting
“…Thus, our findings contribute to the debate about whether appetite hormones act as biomarkers of appetite (De Graaf et al, 2004;A. Flint et al, 2007;Lemmens et al, 2011) and support the notion of the subjective appetite measures being better correlates of energy intake than circulating levels of individually considered appetite hormones (Doucet et al, 2008).…”
Section: Hensd Placebosupporting
confidence: 80%
“…3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64and energy intakes between the two trials. To assess the strength of within-subject relation between changes in appetite scores and changes in hormone and glucose concentrations, regression slopes and R 2 values for the regression of appetite score on hormone and glucose concentrations for the corresponding time points were calculated (Lemmens, Martens, Kester, & Westerterp-Plantenga, 2011). Student's one sample t-tests were used to test whether the means of the regression slopes were different from zero.…”
Section: Discussionmentioning
confidence: 99%
“…For further understanding of relations between responses of appetite scores and hormone responses we used a statistical approach that focuses on within participant relations between changes in appetite scores and changes in hormone concentrations (Lemmens et al, 2011) and obtained regression slopes and R 2 values for the regression of appetite scores on each of the measured appetite hormones. We found that within participant relations between responses of appetite scores and responses of hormones showed significant correlations with regards to PYY and insulin, but not CCK.…”
Keywords:High energy supplements Appetite Appetite hormones Gastric emptying Thermogenesis Control of food intake a b s t r a c t
Background:The net clinical benefit of high-energy nutritional supplements (HENSDs) consumption is lower than expected. Objectives: To investigate the extent to which consumption of oral HENSD in the fasted state reduces energy intake in slim females during consecutive breakfast and lunch, and whether this relates to changes in appetite and metabolic appetite regulators. Design: Twenty three females of 24.4 ± 2.8 years with BMI of 18.2 ± 0.8 kg/m 2 consumed HENSD (2.5 MJ) or PLACEBO (0.4 MJ) in fasted state in a single blind randomized cross-over study. Appetite and metabolic rate measurements and blood collection were conducted prior to and during 240 min after the intake of the supplements. Energy intake was recorded during ad libitum buffet breakfast and lunch served 60 min and 240 min post supplementation respectively. Results: Energy intake during breakfast was significantly (P < 0.01) lower in the HENSD trial but the net cumulative effect on energy intake was 1.07 ± 0.34 MJ higher in the HENSD compared to PLACEBO. Plasma concentration of CCK and PYY and insulin and were significantly (P < 0.05) higher in the HENSD trial while appetite measures were not significantly different between HENSD and PLACEBO trials. Correlations for the within participant relations between the responses of plasma hormones and appetite scores were significant (P < 0.05) for PYY and insulin but not CCK. The energy expended above resting metabolic rate was significantly (P < 0.05) higher in the HENDS trial but relative increase in energy expenditure was not significantly different between the two trials. Conclusion: Oral high-energy nutritional supplements have a partial and relatively short lived suppressive action on energy intake and can be expected to increase net energy intake by approximately half the energy value of the supplement consumed.
“…However, the results must be interpreted with some reservations because the identified associations between appetite sensations and concentrations of appetite hormones were weak and, in some cases, inconsistent with the current literature (ie, PYY 3-36 was inversely associated with satiety, and cholecystokinin was associated with prospective consumption) (41). A comparison of dynamics of appetite sensations with appetite hormones was difficult because of the different timing and responses of individual variables (42). Associations between appetite sensations and appetite hormones need to be explored further.…”
Protein dose-dependently increased satiety and GLP-1, PYY 3-36, and glucagon, which may, at least in part, be responsible for the satiety-stimulating effect of protein. This trial was registered at clinicaltrials.gov as NCT01561235.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.